The etiology of chronic systemic inflammatory diseases such as rheumatoid arthritis is unknown. Nevertheless, the increased incidence and severity of such illnesses in individuals carrying particular alleles of the major histocompatibility complex (MHC), the presence of CD4 (helper) T cells within chronically inflamed tissues and the beneficial effects of depleting CD4 T cells have led to the view that aberrant helper T-cell responses are involved [1] . It has been suggested that an infectious agent, and the consequent activation of pathogen-specific helper T cells, cause rheumatoid arthritis. The similarities between rheumatoid arthritis and better-defined chronic infectious arthritic diseases, such as Lyme disease, and the presence of T cells that can recognize components of bacteria in the synovial tissues of rheumatoid arthritis patients, both support such a position.
As yet, however, no pathogenic agent has been identified that might be responsible for initiating rheumatoid arthritis. An alternative suggestion is that rheumatoid arthritis is the result of pathological manifestations of T-cell autoreactivity caused by a failure of self-tolerance mechanisms. Consistent with this, rheumatoid arthritis is frequently associated with autoantibodies such as rheumatoid factors, and destructive arthritis can be induced in rodents following immunization with constituents of the normal articular cartilage. Perhaps the most attractive hypothesis is that rheumatoid arthritis is caused by some combination of genetic proclivity to autoimmunity and an inciting infectious agent.
Despite the suggestive evidence, many rheumatologists remain unconvinced that T cells are important to the pathogenesis of rheumatoid arthritis. It has been argued that synovial T cells are unlikely to play a causative role in the development of the illness, as such T cells appear to be functionally defective in their responses to mitogenic stimulation in vitro. Indeed, the large quantities of proinflammatory cytokines present in arthritic joints are most indicative of a chronic activation of synoviocytes and other phagocytes [2] .
Mathis and colleagues [3] have recently reported remarkable observations that directly address these issues. Using transgenic mice specifically designed to express a single type of T-cell receptor on each of their CD4 helper T cells, they unexpectedly found that, by one month of age, the mice developed a chronic deforming polyarthritis involving the toes, feet, ankles and knees, as well as the corresponding forelimb joints, a pathology reminiscent of rheumatoid arthritis. Evidence of systemic inflammatory disease was also present, with hypergammaglobulinemia and antibody deposits within multiple tissues. This onset of spontaneous destructive polyarthritis in a T-cell receptor transgenic mouse line is unprecedented.
The T-cell receptor genes used for the production of the transgenic mouse line (called KRN mice) came from a T cell specific for a bovine RNAse peptide antigen presented by an I-A k class II MHC molecule. However, this T-cell receptor was subsequently found to recognize spleen cells from the NOD (non-obese diabetic) strain of mice -that is, KRN T cells could be activated by NOD splenocytes in the absence of RNAse peptide. This particular specificity is of critical importance, as the mice developed arthritis only when the T-cell receptor transgenes were coexpressed with the NOD strain I-A g7 class II MHC molecule, as in the transgenic offspring of a cross between KRN and NOD mice (KRN × NOD F 1 mice). Thus, the spontaneous development of arthritis seems to depend on the recognition of self I-A g7 molecules (and some endogenous self-peptide) by the KRN transgenic T-cell receptor. Final proof will depend on the demonstration that arthritis also develops in mice that express the KRN transgenic T-cell receptor in the absence of other endogenous T-cell receptors, for example mice containing targeted mutations in the endogenous T-cell receptor ␣ locus.
T cells capable of responding against self MHC molecules are usually killed before their maturation in the thymus, in order to maintain immune self-tolerance [4] . Consistent with this, most of the immature T cells were found to be killed in the KRN × NOD F 1 mice early in life. However, with increasing age and before the development of arthritis, CD4 helper T cells accumulated in the thymus, spleen and synovial fluid. A higher proportion of these cells seemed to express endogenously rearranged T-cell receptor genes -encoding ␣ and/or ␤-chains -and made reduced levels of the transgenic ␣␤ heterodimer, perhaps suggesting that the cells with the highest level of autoreactive T-cell receptor expression were preferentially eliminated during their development. Additionally, the peripheral T cells were more likely to express activation markers -CD44 high , CD62L low and CD45RB lowindicating a recent recognition of antigen in the periphery.
This age-associated failure of intrathymic clonal deletion of the T-cell receptor transgenic T cells could reflect a progressive reduction in the thymic expression of I-A g7 or the relevant self-peptide presented by this MHC molecule. Alternatively, clonal deletion may simply be overwhelmed by the large number of maturing autoreactive CD4 helper-type T cells that can be generated in the thymus in these mice. The solution to this problem awaits the isolation and identification of the self-peptide responsible for the apparent autoreactivity in this model. Regardless of the mechanism, the spontaneous development of polyarthritis in the KRN × NOD F 1 mice appears to begin with a breakdown in thymic self-tolerance to a widely-distributed self-peptide-MHC class II molecule complex. This discovery provides strong evidence that autoreactive T cells can initiate a disease like rheumatoid arthritis.
A paradoxical feature of this study is that, at a time when the mice were affected by arthritis, peripheral T-cell receptor transgenic T cells were found to be almost completely unresponsive to stimulation in vitro with the RNAse peptide. This functional impairment suggests that a peripheral tolerance mechanism has attempted to inhibit their autoaggressive behavior. Other recent studies on the fate of T-cell receptor transgenic T cells following in vivo exposure to antigen have indicated that antigen stimulation in the presence of inflammation caused by adjuvants or microbial products induces proliferation and the maintenance of antigen responsiveness, but that antigen recognition in the absence of inflammation induces only transient proliferation in the spleen and lymph nodes followed by a partial peripheral deletion, with the surviving T cells left in an 'anergic' or functionally impaired state 
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Self-reactive T cell Clonal deletion in thymus T cells specific for foreign antigens [5] . In the absence of a pathogen or injury, such a tolerance-inducing environment would be expected when the KRN T cells encounter self-antigen in the periphery. Peripheral deletion of T-cell receptor transgenic T cells may or may not occur in the older KRN × NOD F 1 mice; regardless, the accumulation of anergic T cells with a recently activated phenotype is consistent with peripheral tolerance induction upon recognition of self-antigen.
Despite the in vitro functional impairment exhibited by the T-cell receptor transgenic T cells from older KRN × NOD F 1 mice, these animals still developed destructive polyarthritis, presumably as a consequence of the accumulation of autoreactive CD4 helper T cells in the joints. This implies a failure of peripheral tolerance mechanisms to block the development of pathological self-reactivity. This failure is perhaps not unexpected, as peripheral tolerance mechanisms may not be capable of globally suppressing all the potential effector responses of such helper T cells [6] . Although T-cell clonal anergy in vitro is manifested by a profound block in interleukin-2 (IL-2) production and clonal expansion, the production of interferon-␥ and IL-4 is relatively unaffected, as is expression of cytotoxic activity [7] . Likewise, experiments designed to induce peripheral T-cell tolerance in vivo have failed to demonstrate a significant effect on the helper activity of the T cells if they are first primed (and presumably expanded) in response to immunization with antigen and adjuvant [8] .
Anergic T cells in vivo may therefore be impaired in their ability to undergo clonal expansion, but may still be capable of influencing the development of B-cell antibody responses or killing antigen-bearing target cells. Under normal circumstances, this type of functional unresponsiveness would be effective at preventing autoimmunity by limiting the capacity of self-antigen-specific T cells to expand to large numbers in the periphery (Fig. 1a) . This effectiveness may be lost in the setting of the older KRN × NOD F 1 mice, because self-antigen-specific T cells escape the thymus in large numbers every day. Thus, even though these T cells acquire a proliferative defect because of peripheral tolerance induction, they would be numerous enough to facilitate the effector responses that cause autoimmune pathology (Fig. 1b) . The earlier finding by Forster et al. [9] that peripheral tolerance was maintained in self-antigen-specific T cells when they were present at low frequency, whereas at a higher frequency these same cells caused autoimmune pathology, supports this idea.
This situation may also describe the dynamics of T-cell participation in the initiation of clinically important autoimmunity in people who eventually develop a systemic inflammatory polyarthritis. Perhaps such individuals accumulate self-antigen-specific T cells to relatively high numbers as a consequence of infection -given its potential for simultaneous expansion of bystander or cross-reactive self-antigen-specific T-cell clones -in the setting of a genetically pre-determined weakness in peripheral tolerance (Fig. 1c) . Then, despite the best efforts of the immune system to inactivate these T cells, they retain the capacity to initiate and perpetuate an inflammatory response directed against that self-antigen. The observation that CD4 helper T cells within the synovial tissues of rheumatoid arthritis patients show little capacity for IL-2 secretion or proliferation, and yet retain a remarkable capacity to provide help to B cells for the production of antibodies [10] , is consistent with such a scenario.
